Ascending thoracic aneurysms are associated with decreased systemic atherosclerosis

Chest

Volumn 128, Issue 3, 2005, Pages 1580-1586

  Achneck, Hardean ^a   Modi, Biren ^a   Shaw, Coralie ^a   Rizzo, John ^b   Albornoz, Gonzalo ^a   Fusco, Daniel ^a   Elefieriades, John ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Aneurysm; Aorta; Atherosclerosis; Dissection

Indexed keywords

ADULT; AGE; AGED; AORTA DISSECTING ANEURYSM; AORTA ROOT; ARTICLE; ATHEROSCLEROSIS; CALCIFICATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE MARKER; DYSLIPIDEMIA; FEMALE; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; SMOKING; THORACIC AORTA ANEURYSM;

EID: 24944511485     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.128.3.1580     Document Type: Article

References (23)

1. Coady MA, Davies RR, Roberts M, et al. Familial patterns of thoracic aortic aneurysms. Arch Surg 1999; 134:361-367
2. Hoyert DL, Arias E, Smith BL, et al. Deaths: final data for 1999. Natl Vital Stat Rep 2001; 49:1-113
3. Allison MA, Criqui MH, Wright CM. Patterns and risk factors for systemic calcified atherosclerosis. Arterioscler Thromb Vasc Biol 2004; 24:331-336
4. Rizzo JA, Coady MA, Elefteriades JA. Interpreting data on thoracic aortic aneurysms: statistical issues. Cardiol Clin 1999; 17:797-805.
5. Hagl C, Strauch JT, Spielvogel D, et al. Is the Bentall procedure for ascending aorta or aortic valve replacement the best approach for long-term event-free survival? Ann Thorac Surg 2003; 76:698-703
6. Islamoglu F, Atay Y, Can L, et al. Diagnosis and treatment of concomitant aortic and coronary disease: a retrospective study and brief review. Tex Heart Inst J 1999; 26:182-188
7. Agmon Y, Khandheria BK, Meissner I, et al. Is aortic dilatation an atherosclerosis-related process? Clinical, laboratory, and transesophageal echocardiographic correlates of thoracic aortic dimensions in the population with implications for thoracic aortic aneurysm formation. J Am Coll Cardiol 2003; 42:1076-1083
8. Nakashima Y, Kurozumi T, Sueishi K, et al. Dissecting aneurysm: a clinicopathologic and histopathologic study of 111 autopsied cases. Hum Pathol 1990; 21:291-296
9. Kojima S, Suwa S, Fujiwara Y, et al. Incidence and severity of coronary artery disease in patients with acute aortic dissection: comparison with abdominal aortic aneurysm and arteriosclerosis obliterans. J Cardiol 2001; 37:165-171
10. Wilson K, Whyman M, Hoskins P, et al. The relationship between abdominal aortic aneurysm wall compliance, maximum diameter and growth rate. Cardiovasc Surg 1999; 7:208-213
11. Koullias GJ, Modak R, Tranquilli M, et al. Mechanical deterioration underlies malignant behavior of aneurysmal human ascending aorta. J Thorac Cardiovasc Surg 2005 (in press)
12. Nagai Y, Helwegen J, Fleg JL, et al. Associations of aortic Windkessel function with age, gender and cardiovascular risk factors. Ultrasound Med Biol 2001; 27:1207-1210
13. Maeta H, Hori M. Effects of a lack of aortic "Windkessel" properties on the left ventricle. Jpn Circ J 1985; 49:232-237
14. Dart AM, Kingwell BA. Pulse pressure: a review of mechanisms and clinical relevance. J Am Coll Cardiol 2001; 37:975-984
15. Guo D, Hasham S, Kuang SQ, et al. Familial thoracic aortic aneurysms and dissections: genetic heterogeneity with a major locus mapping to 5q13-14. Circulation 2001; 103: 2461-2468
16. Muller BT, Modlich O, Prisack HB, et al. Gene expression profiles in the acutely dissected human aorta. Eur J Vasc Endovasc Surg 2002; 24:356-364
17. Koullias GJ, Ravichandran P, Korkolis DP, et al. Increased tissue microarray matrix metalloproteinase expression favors proteolysis in thoracic aortic aneurysms and dissections. Ann Thorac Surg 2004; 78:2106-2110
18. Bendeck MP. Matrix metalloproteinases: are they antiatherogenic but proaneurysmal? Circ Res 2002; 90:836-837
19. Silence J, Collen D, Lijnen HR. Reduced atherosclerotic plaque but enhanced aneurysm formation in mice with inactivation of the tissue inhibitor of metalloproteinase-1 (TIMP-1) gene. Circ Res 2002; 90:897-903
20. Ye S, Watts GF, Mandalia S, et al. Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis. Br Heart J 1995; 73:209-215
21. Humphries SE, Luong LA, Talmud PJ, et al. The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study: Lopid Coronary Angiography Trial. Atherosclerosis 1998; 139:49-56
22. Vaughan CJ, Casey M, He J, et al. Identification of a chromosome 11q23.2-q24 locus for familial aortic aneurysm disease, a genetically heterogeneous disorder. Circulation 2001; 103:2469-2475
23. Pendas AM, Santamaria I, Alvarez MV, et al. Fine physical mapping of the human matrix metalloproteinase genes clustered on chromosome 11q22.3. Genomics 1996; 37:266-268